The Bulletin: Seoul Eye Clinic Contributes Long-Term Clinical Data to International Cataract and Refractive Surgery Research Seoul Eye Clinic Contributes Long-Term Clinical Data to International Cataract and Refractive Surgery Research The Daily Tribune News: Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and ... Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and ... Seeking Alpha: Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication Ophthalmology Times: Multiple Presentations Offer Insight to Cataract Surgeons About the Ocular Surface and Outflow in Glaucoma Surgery A trio of ASCRS presentations collectively offer insight to surgeons, suggesting that glaucoma drops harm meibomian glands, while combining cataract surgery with MIGS can boost long-term IOP control.

Context Explanation